Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY System

Johan Löf, Founder and CEO of RaySearch, remarked, "The OXRAY system represents a remarkable convergence of advanced radiotherapy technologies. By combining non-coplanar treatments, superior imaging capabilities, a conventional MLC, and real-time tracking, OXRAY delivers a new level of precision and flexibility. The integration with RayStation underscores our commitment to pioneering solutions that enhance cancer treatments.”

RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi. The event took place on June 17 at Narita Memorial Hospital in Toyohashi, Japan.

OXRAY represents a pioneering radiotherapy system featuring a Gimbal-mounted beam delivery system. RayStation was used to drive its motion tracking functionality, dual-source CBCT image-guided radiotherapy for precise patient positioning, and dynamic swing arc capabilities. Developed in collaboration with Kyoto University Hospital, the OXRAY system has been seamlessly integrated into RayStation through close collaboration between RaySearch and Hitachi.

By joining the innovative capabilities of OXRAY with RayStation’s sophisticated planning software, clinicians can achieve unprecedented precision and flexibility in radiation therapy, ensuring optimal patient outcomes.

Dr. Yuta Shibamoto, MD of the Meiyo-kai Narita Memorial Hospital group says: “There are so many different cases and challenges we face in daily practice. Having the latest technique will enhance the possibilities of our treatment. We are looking forward to the solution that OXRAY and RayStation brings in.”

Johan Löf, Founder and CEO of RaySearch, remarked, “The OXRAY system represents a remarkable convergence of advanced radiotherapy technologies. By combining non-coplanar treatments, superior imaging capabilities, a conventional MLC, and real-time tracking, OXRAY delivers a new level of precision and flexibility. The integration with RayStation underscores our commitment to pioneering solutions that enhance cancer treatments.”

IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market

“Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for these technologies is growing due to increasing healthcare needs, advancements in medical devices and rising demand for efficient patient care.”

Advertise With Us

Join Our Family

Of Advertisers
Click Here